Study uncovers key biological pathways driving psoriasis inflammation

FHS
May 21, 2024
3:21 am

A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds.

Astellas withdraws lawsuit after evading Medicare drug price negotiations

WASHINGTON — Astellas was so sure that one of its drugs was going to be selected as part of Medicare’s new drug price negotiation program

September 6, 2023

Wet AMD biotech stock soars over 200% as lead asset matches Regeneron’s Eylea in PhII test

EyePoint Pharmaceuticals’ wet age-related macular degeneration (AMD) therapy has demonstrated non-inferiority to Regeneron’s Eylea, even with a less frequent dosing regimen in a mid-stage study,

December 5, 2023

How healthy plant-based diets enhance strength and function in aging adults

A study links healthy plant-based diets to improved physical performance and strength in aging adults, emphasizing diet quality over quantity.

December 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.